TKNO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. TKNO is in a sharp bearish breakdown (down ~14.8% in the regular session) with moving averages stacked bearishly and MACD worsening. While RSI is extremely oversold and options positioning leans bullish, there is no Intellectia buy signal today and price is trading below/around near-term support—this is a “falling knife” setup better avoided by an impatient buyer.
Trend/price action: Strong short-term downtrend (regular session -14.79%; post-market ~2.41–2.42). Momentum: MACD histogram -0.0871 and negatively expanding (bearish acceleration). RSI: RSI_6 at 5.70 = extremely oversold (bounce potential exists, but trend is still down). Moving averages: Bearish stack (SMA_200 > SMA_20 > SMA_5), confirming a sustained downtrend. Levels: Pivot 3.062 (well above price), Resistance R1 3.633 / R2 3.986. Support S1 2.491 is being tested/undercut; next support S2 2.138 (downside reference if weakness persists). Pattern model: Similar-candlestick study suggests elevated bounce odds (next day +9.44% and next month +18.17%), but this conflicts with the current breakdown—without a confirmed reversal, it’s not a high-quality entry.
Intellectia Proprietary Trading Signals
+9.17% YoY, showing top-line expansion.
Technical breakdown with bearish MA stack and worsening MACD suggests selling pressure is still dominant; price is below/near S1 with room to S2 (~2.14). Profitability deteriorated in 2025/Q3: net loss widened (Net Income -$4.286M, -43.34% YoY) and EPS fell (-0.08, -46.67% YoY). Gross margin reported as significantly lower (27.92, large YoY drop), pointing to operational pressure. No supportive near-term news/catalysts in the past week. No hedge fund or insider accumulation signals recently (both neutral).
Latest quarter: 2025/Q3. Growth: Revenue rose to $10.454M (+9.17% YoY), indicating continued sales growth. Profitability: Net income declined to -$4.286M (loss widened, -43.34% YoY) and EPS decreased to -0.08 (-46.67% YoY), showing worsening earnings leverage. Margins: Gross margin reported at 27.92 with a very large YoY decline, consistent with cost/mix pressure. Overall: improving top line but weakening profitability—this is not the kind of fundamental momentum that typically supports buying into a sharp technical downtrend.
No analyst rating or price target change data was provided, so there is no observable recent Wall Street upgrade/downgrade or target-trend to lean on. Pros (likely view): revenue growth and potential rebound after oversold selloff. Cons (likely view): deteriorating profitability/margins and weak technicals with no clear catalyst. Influential trading: no recent congress trading data available; hedge funds and insiders are neutral with no significant recent trend.
